Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippa Newell

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenibAnja Lachenmayer, Clara Alsinet, Radoslav Savic, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 3, 2020
Management of early hepatocellular carcinoma: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary AssociationSepideh Gholami, Lauren M Perry, Jason W Denbo, et al.
Gastroenterology|February 16, 2011
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinomaAugusto Villanueva, Yujin Hoshida, Carlo Battiston, et al.
NPJ Breast Cancer|March 18, 2026
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancerAlan Su, Erin C Hong, Nicole Moxon, et al.
Cancer Research|August 15, 2008
Focal gains of VEGFA and molecular classification of hepatocellular carcinomaDerek Y Chiang, Augusto Villanueva, Yujin Hoshida, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenibAnja Lachenmayer, Clara Alsinet, Radoslav Savic, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 3, 2020
Management of early hepatocellular carcinoma: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary AssociationSepideh Gholami, Lauren M Perry, Jason W Denbo, et al.
Gastroenterology|February 16, 2011
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinomaAugusto Villanueva, Yujin Hoshida, Carlo Battiston, et al.
NPJ Breast Cancer|March 18, 2026
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancerAlan Su, Erin C Hong, Nicole Moxon, et al.
Cancer Research|August 15, 2008
Focal gains of VEGFA and molecular classification of hepatocellular carcinomaDerek Y Chiang, Augusto Villanueva, Yujin Hoshida, et al.
Pageof 2